Customization: | Available |
---|---|
CAS No.: | N/a |
Formula: | C33h57n11o9 |
Still deciding? Get samples of $ !
Request Sample
|
Suppliers with verified business licenses
Audited by an independent third-party inspection agency
Product Name | Orforglipron |
CAS NO. | 2212020-52-3 |
Appearance | White powder |
Purity | 98% HPLC |
Application | Research peptides |
Shelf Life | 24 Months |
Storage | Store at a temperature of 2-8 degrees, protected from light. |
Orforglipron (LY-3502970) is an oral, non-peptide, small-molecule GLP-1 receptor agonist developed as a weight loss drug by Eli Lilly and Company. It was discovered by Chugai Pharmaceutical Co., then was licensed to Lilly in 2018.Orforglipron is easier to produce than existing peptide GLP-1 agonists and is expected to be cheaper.
For Research Purpose Only.